A Preclinical Contract Research Organization Blog Compendium

In Vivo PK Studies Driving Faster Drug Development Decisions

One of the most common reasons promising drug candidates fail during development is not a lack of biological activity, but poor pharmacokinetic behavior.

5 Things Every Sponsor Should Know Before a Study Begins

The most successful studies don’t begin with the first dose, the first data point, or even the kickoff meeting. They begin much earlier, at the moment

Operational Excellence in AAV Biodistribution

Gene therapies, particularly those utilizing Adeno-associated viruses (AAV) vectors, have moved beyond the proof-of-concept phase into a

Lab Technicians: The Unsung Heroes Driving Research Success

At Attentive Science, our laboratory technicians are more than technical experts; they are collaborators and real-time problem-solvers

Preclinical Development Is a Strategy, Not Just a Service

Preclinical development is no longer a simple checkpoint on the path to the clinic; it is a strategic inflection point that can accelerate momentum

The Future of CROs: Not AI vs Humans, But AI With Humans.

As 2025 closed, one question dominated life sciences: Will artificial intelligence (AI) replace humans in drug development?

Why GLP Still Matters Beyond GLP-1 Trends

GLP dominates today’s research conversations, yet it’s often misunderstood as something entirely different.

How Nonclinical Research Protects the Holiday Table

Thanksgiving traditions revolves around family recipes and seasonal favorites, but the safety of the food table also depends on something far

Predictive Modelling Continues to Shape Toxicology

As the volume and complexity of nonclinical toxicology data continue to grow, the industry is seeing a shift toward predictive modelling,